|
|||||
|
|
Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add-on to sodium-glucose co-transporter-2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes |
|
| Authors: | Athena Philis-Tsimikas MD Liana K. Billings MD Robert Busch MD Cristobal Morales Portillo MD Rakesh Sahay MD Natalie Halladin MD Sarah Eggert MD Kamilla Begtrup MSc Stewart Harris MD |
| Affiliation: | 1. Scripps Whittier Diabetes Institute, San Diego, California;2. NorthShore University HealthSystem, Skokie, Illinois University of Chicago Pritzker School of Medicine, Chicago, Illinois;3. Albany Medical Centre, Albany, New York;4. Hospital Virgen Macarena, Seville, Spain;5. Osmania Medical College, Hyderabad, India;6. Novo Nordisk, Søborg, Denmark;7. Western University, London, Ontario, Canada |
| Abstract: | |
| Keywords: | GLP-1 analogue insulin therapy liraglutide randomized trial SGLT2 inhibitor type 2 diabetes |